Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M600477200 on February 22, 2006

J. Biol. Chem., Vol. 281, Issue 16, 11405-11412, April 21, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
281/16/11405    most recent
M600477200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wesche, J.
Right arrow Articles by Olsnes, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wesche, J.
Right arrow Articles by Olsnes, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

FGF-1 and FGF-2 Require the Cytosolic Chaperone Hsp90 for Translocation into the Cytosol and the Cell Nucleus*

Jørgen Wesche{ddagger}1, Jedrzej Malecki{ddagger}2, Antoni Wiedlocha{ddagger}, Camilla Skiple Skjerpen{ddagger}, Peter Claus§, and Sjur Olsnes{ddagger}

From the {ddagger}Institute for Cancer Research at the Norwegian Radium Hospital, University of Oslo, Montebello, 0310 Oslo, Norway and the §Department of Neuroanatomy, Hannover Medical School, D-30625 Hannover, Germany

Similarly to many protein toxins, the growth factors fibroblast growth factor 1 (FGF-1) and FGF-2 translocate from endosomes into the cytosol. It was recently found that certain toxins are dependent on cytosolic Hsp90 for efficient translocation across the endosomal membrane. We therefore investigated the requirement for Hsp90 in FGF translocation. We found that low concentrations of the specific Hsp90 inhibitors, geldanamycin and radicicol, completely blocked the translocation of FGF-1 and FGF-2 to the cytosol and the nucleus. The drugs did not interfere with the initial binding of FGF-1 to the growth factor receptors at the cell-surface or with the subsequent internalization of the growth factors into endosomes. The activation of known signaling cascades downstream of the growth factor receptors was also not affected by the drugs. The data indicate that the drugs block translocation from endosomes to the cytosol implying that Hsp90 is required for translocation of FGF-1 and FGF-2 across the endosomal membrane.


Received for publication, January 17, 2006 , and in revised form, February 22, 2006.

* This work was supported by the Norwegian Cancer Society, the Novo Nordisk Foundation, the Norwegian Research Council, Blix Fund for the Promotion of Medical Research, Rachel and Otto Kr. Bruun's legat, Ragnar Mørk's legat, Torsteds legat, and by the Jahre Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

2 Present address: Inst. of Medical Biochemistry, Medical College Jagiellonian University, 31-034 Krakow, Poland.

1 To whom correspondence should be addressed. Tel.: 47-22-93-42-93; Fax: 47-22-50-86-92; E-mail: jorgen.wesche{at}labmed.uio.no.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
V. Stepanova, T. Lebedeva, A. Kuo, S. Yarovoi, S. Tkachuk, S. Zaitsev, K. Bdeir, I. Dumler, M. S. Marks, Y. Parfyonova, et al.
Nuclear translocation of urokinase-type plasminogen activator
Blood, July 1, 2008; 112(1): 100 - 110.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
V. Sorensen, Y. Zhen, M. Zakrzewska, E. M. Haugsten, S. Walchli, T. Nilsen, S. Olsnes, and A. Wiedlocha
Phosphorylation of Fibroblast Growth Factor (FGF) Receptor 1 at Ser777 by p38 Mitogen-Activated Protein Kinase Regulates Translocation of Exogenous FGF1 to the Cytosol and Nucleus
Mol. Cell. Biol., June 15, 2008; 28(12): 4129 - 4141.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J Buratini Jr., M.G.L Pinto, A.C Castilho, R.L Amorim, I.C Giometti, V.M Portela, E.S Nicola, and C.A Price
Expression and Function of Fibroblast Growth Factor 10 and Its Receptor, Fibroblast Growth Factor Receptor 2B, in Bovine Follicles
Biol Reprod, October 1, 2007; 77(4): 743 - 750.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
H. Zheng, J. Shi, X. Fang, Y. Li, S. Vang, W. Fan, J. Wang, Z. Zhang, W. Wang, K. Kristiansen, et al.
FGF: A web tool for Fishing Gene Family in a whole genome database
Nucleic Acids Res., July 13, 2007; 35(suppl_2): W121 - W125.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
V. Sorensen, A. Wiedlocha, E. M. Haugsten, D. Khnykin, J. Wesche, and S. Olsnes
Different abilities of the four FGFRs to mediate FGF-1 translocation are linked to differences in the receptor C-terminal tail
J. Cell Sci., October 15, 2006; 119(20): 4332 - 4341.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement